{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:21:28Z","timestamp":1776450088659,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.transproceed.2011.04.017","type":"journal-article","created":{"date-parts":[[2011,9,11]],"date-time":"2011-09-11T19:08:43Z","timestamp":1315768123000},"page":"2699-2706","source":"Crossref","is-referenced-by-count":12,"title":["Improvement in Chronic Renal Failure after Mycophenolate Mofetil Introduction and Cyclosporine Dose Reduction: Four-Year Results From a Cohort of Heart Transplant Recipients"],"prefix":"10.1016","volume":"43","author":[{"given":"N.","family":"Manito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"R\u00e1bago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Ariz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Almenar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Crespo-Leiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pulp\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2011.04.017_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.healun.2007.06.004","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report\u20142007","volume":"26","author":"Taylor","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.04.017_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2011.04.017_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/qjmed\/89.10.751","article-title":"Cyclosporin nephrotoxicity in heart and lung transplant patients","volume":"89","author":"Griffiths","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.transproceed.2011.04.017_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.04.017_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00007890-199807150-00007","article-title":"Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients","volume":"66","author":"Zanker","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.04.017_bib6","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/00007890-199806150-00019","article-title":"Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report","volume":"65","author":"Ducloux","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.04.017_bib7","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/00007890-199812270-00027","article-title":"Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function","volume":"66","author":"Hueso","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.04.017_bib8","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.ehj.2004.06.032","article-title":"Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients\u2014the IMPROVED multi-centre study","volume":"25","author":"Angermann","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.transproceed.2011.04.017_bib9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0041-1345(03)00360-9","article-title":"Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine","volume":"35","author":"Baryalei","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.04.017_bib10","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1053-2498(02)00422-9","article-title":"Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil","volume":"21","author":"Tedoriya","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.04.017_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0041-1345(01)02830-5","article-title":"Use of mycophenolate mofetil in patients with transplanted heart and renal insufficiency: the relevance of the pharmacokinetic study","volume":"34","author":"Arizon del Prado","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.04.017_bib12","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/00007890-200004270-00012","article-title":"Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine","volume":"69","author":"Aleksic","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.04.017_bib13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0041-1345(00)02426-X","article-title":"Rescue therapy: a role for sirolimus in lung and heart transplant recipients","volume":"33","author":"Snell","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.04.017_bib14","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"issue":"2 suppl 1","key":"10.1016\/j.transproceed.2011.04.017_bib15","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2011.04.017_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy","volume":"311","author":"Myers","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2011.04.017_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.healun.2008.07.019","article-title":"Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation","volume":"27","author":"Hertz","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.04.017_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-199703150-00009","article-title":"Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression","volume":"63","author":"Goldstein","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.04.017_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.healun.2006.05.001","article-title":"Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients","volume":"25","author":"Kobashigawa","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.04.017_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1440-1797.2006.00548.x","article-title":"Preliminary experience with mycophenolate mofetil for preservation of renal function in cardiac transplant patients with documented cyclosporine nephrotoxicity","volume":"11","author":"Al-Aly","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.transproceed.2011.04.017_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/TP.0b013e3181963371","article-title":"Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure","volume":"87","author":"Groetzner","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.04.017_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trim.2006.02.001","article-title":"Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients","volume":"16","author":"Schweiger","year":"2006","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2011.04.017_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.healun.2007.11.565","article-title":"Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients","volume":"27","author":"Ross","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.04.017_bib24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/TP.0b013e31819452ce","article-title":"Progression of renal dysfunction in cardiac transplantation after the introduction of everolimus in the immunosuppressive regime","volume":"87","author":"Moro Lopez","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.04.017_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2004-820880","article-title":"First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation","volume":"52","author":"Trosch","year":"2004","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.transproceed.2011.04.017_bib26","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.healun.2005.02.018","article-title":"Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation","volume":"24","author":"Hunt","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.04.017_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.tp.0000177644.45192.a3","article-title":"Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up","volume":"81","author":"Bestetti","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.04.017_bib28","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2011.04.017_bib29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511008529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511008529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T04:31:41Z","timestamp":1543552301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134511008529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0041134511008529"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2011.04.017","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}